课题基金 / 基金详情

Regulation of Chromatin Remodeling and Transcription Involved in Tumor suppression and its Dysregulation in Oral Cancer

Regulation of Chromatin Remodeling and Transcription Involved in Tumor suppression and its Dysregulation in Oral Cancer
口腔癌中参与肿瘤抑制及其失调的染色质重塑和转录的调节
批准号:
16209054
负责人:
IKEDA Masa-aki
金额:
$29.37万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2007

项目摘要

项目成果

IKEDA Masa-aki的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Previously, we have reported that DRIL1, an ARID (AX-rich interaction domain) DNA-binding protein, is regulated by p53 tumor suppressor. In this study, we investigated functional roles of DRIL1 in the p53 regulatory pathway, and dysregulation of its pathway in oral cancer. Here we show that DRIL1 specifically binds to the promoter of p21Waf1/Cip1, a p53-target gene important for cell cycle arrest Mutation of the DRIL1 binding sites diminished transactivation of the p21 promoter following p53 overexpression and DNA damage. Consistently, DRIL1 overexpression induces p21 transcription and co-expression of DRIL1 with p53 synergistically activates the p21 promoter. Furthermore, We also identified in vivo binding sites of DRIL1 in pro-apoptotic p53-target genes. Co-expression of DRIL1 and p53 synergistically induces pro-apoptotic gene expression and facilitated p53-mediated apoptosis. Silencing DRIL1 expression by DRILL shRNA down-regulated transcription of p53-target genes and apoptosis ind … More uced by DNA damage, indicating that DRIL1 play an important role in p53-target gene expression and apoptosis. Moreover, DRIL1 directly binds to p53 and PML, a component of PML nuclear bodies (NBs), in which many proteins involved in post translational modifications of p53 are co localized Consistently, we have found that silencing DRIL1 expression by siRNA surely impaired acetylation and phosphorylation of p53, suggesting that DRIL1 plays a role in the post-translational modifications of p53 protein. In a separate study, we found that the defect in phosphorylation of p53 on Ser46 accounts for the acquisition of the p53 resistance in HSC-3 oral cancer cells. Furthermore, coinfection of adenoviruses expressing DRIL1 and p53 efficiently induced apoptosis in p53-resistant HSC-3 cells accompanied by induction of pro-apoptotic p53-target genes. Collectively, these results demonstrate that DRIL1 is a p53-regulated transcription factor that cooperates with p53 to strengthen p53 dependent transcription and trigger apoptosis through its direct binding to p53-target genes, suggesting a positive autoregulatory mechanism of the p53 pathway. Less
期刊论文(106)
专著(0)
科研奖励(0)
会议论文
Tke Defect in Ser46 Phosphorylation of p53 Contributes to the Mechanism of Acquired Resistance to p53 Gene Therapy in Oral Squamous Cell Carcinoma Cells
p53 Ser46 磷酸化的 Tke 缺陷导致口腔鳞状细胞癌细胞对 p53 基因治疗获得性耐药机制
DOI: --
发表时间: 2008
期刊: J. Oral Biosciences (印刷中)
影响因子: --
作者: [Ichwan SJA, Ikeda MA]
通讯作者: Ikeda MA
Ubc9 and protein inhibitor of activated STAT 1 activate Chicken Ovalbumin Upstream Promoter-Transcription Factor I-mediated hhuman CYP11B2 gene transcription
Ubc9 和激活 STAT 1 的蛋白抑制剂激活鸡卵清蛋白上游启动子转录因子 I 介导的人 CYP11B2 基因转录
DOI: --
发表时间: 2005
期刊: J. Biol. Chem. 280
影响因子: --
作者: [Kurihara I, Shibata H, Kobayashi S, Suda N, Ikeda Y, Yokota K, Murai A, Saito I, Rainey WE, Saruta T.]
通讯作者: Saruta T.
Cytoplasmic sequestration of cyclin D1 associate with cell cycle withdrawal of neuroblastoma cells.
细胞周期蛋白 D1 的细胞质隔离与神经母细胞瘤细胞的细胞周期退出相关。
DOI: --
发表时间: 2006
期刊: Biochem.Biophys.Res.Commun. 340
影响因子: --
作者: [Sumrejkanchankij P, Eto K, Ikeda MA.]
通讯作者: Ikeda MA.
DOI: 10.1016/s1349-0079(08)80025-4
发表时间: 2008
期刊: Journal of Oral Biosciences
影响因子: 2.4
作者: [Tamaki Suganuma;M. Ikeda]
通讯作者: Tamaki Suganuma;M. Ikeda
66
    Alternations of Transcriptional Regulation in Oral Cancers and Analysis of Tumor Suppressive functions of p300 Transcriptional Co-activator
    • 批准号:
      13470399
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.22万
    • 财政年份:
      2001
    • 负责人:
      IKEDA Masa-aki
    • 依托单位:
    Alternations of the Transcriptional Co-activator p300 in Oral Cancers and Its Novel Role in Tumor Suppression
    • 批准号:
      10470400
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $8.7万
    • 财政年份:
      1998
    • 负责人:
      IKEDA Masa-aki
    • 依托单位: